approval · primary record
ADO-TRASTUZUMAB EMTANSINE
FDA · BLA · 2026-03-26
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-03-26 |
| Brand | KADCYLA |
| Sponsor | GENENTECH |
| Route | SINGLE-USE |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:41:02.276Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ADO-TRASTUZUMAB EMTANSINE:2026-03-26
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Ado-Trastuzumab Emtansine · compound